Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Molecular Genetics

• Publication date

  2013-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddt145PMID 23569079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current status of the congenital myasthenic syndromes.

  2012influential reference
• Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations

  2012cited by this paper
• Congenital myasthenic syndrome: a brief review.

  2012influential reference
• Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.

  2012cited by this paper
• Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.

  2011cited by this paper
• Structure, expression, and regulation of UDP-GlcNAc: dolichol phosphate GlcNAc-1-phosphate transferase (DPAGT1).

  2009cited by this paper
• Expression and characterization of soluble forms of the extracellular domains of the β, γ and ε subunits of the human muscle acetylcholine receptor

  2006cited by this paper
• Molecular architecture of the neuromuscular junction

  2006cited by this paper
• Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor.

  2006cited by this paper
• N-Linked Glycosylation Is Required for Nicotinic Receptor Assembly but Not for Subunit Associations with Calnexin*

  2005cited by this paper
• Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome

  2004cited by this paper
• O‐GlcNAc turns twenty: functional implications for post‐translational modification of nuclear and cytosolic proteins with a sugar

  2003cited by this paper
• Glycobiology of the neuromuscular junction

  2003cited by this paper
• Glucosamine-6-phosphate synthase--the multi-facets enzyme.

  2002cited by this paper
• A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle.

  2001cited by this paper
• Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle

  2001cited by this paper
• Altered Glycosylation Sites of the δ Subunit of the Acetylcholine Receptor (AChR) Reduce αδ Association and Receptor Assembly*

  1999cited by this paper
• N-glycosylation at the conserved sites ensures the expression of properly folded functional ACh receptors.

  1997cited by this paper
• Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit.

  1996cited by this paper
• Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ε subunit

  1996influential reference
• Functional and non‐functional isoforms of the human muscle acetylcholine receptor.

  1995cited by this paper
• Role for a synapse-specific carbohydrate in agrin-induced clustering of acetylcholine receptors.

  1995cited by this paper
• Site-directed mutagenesis of the conserved N-glycosylation site on the nicotinic acetylcholine receptor subunits.

  1991cited by this paper
• Mutational analysis of muscle nicotinic acetylcholine receptor subunit assembly

  1990cited by this paper
• Altered patterns of N-linked glycosylation of the Torpedo acetylcholine receptor expressed in Xenopus oocytes.

  1990cited by this paper
• The human muscle nicotinic acetylcholine receptor alpha‐subunit exist as two isoforms: a novel exon.

  1990cited by this paper
• Assembly and N-glycosylation of all ACh receptor subunits are required for their efficient insertion into plasma membranes.

  1989cited by this paper
• A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671

  1989cited by this paper
• The human medulloblastoma cell line TE671 expresses a muscle‐like acetylcholine receptor Cloning of the α‐subunit cDNA

  1988cited by this paper
• The effects of inhibiting oligosaccharide trimming by 1-deoxynojirimycin on the nicotinic acetylcholine receptor.

  1986cited by this paper
• Carbohydrate structures of acetylcholine receptor from Torpedo californica and distribution of oligosaccharides among the subunits.

  1986cited by this paper
• Effect of tunicamycin, an inhibitor of protein glycosylation, on the biological properties of acetylcholine receptor in cultured muscle cells.

  1983cited by this paper
• Inhibition of glycosylation with tunicamycin blocks assembly of newly synthesized acetylcholine receptor subunits in muscle cells.

  1982cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture.

  1980cited by this paper

• When Facioscapulohumeral dystrophy Meets Myasthenia gravis: Case Report and Literature Review

  2025cites this paper
• GFPT1-related congenital myasthenic syndrome misdiagnosed as myopathy: clinical and genetic insights

  2025cites this paper
• Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice.

  2025cites this paper
• The spectrum of neuromuscular diseases with tubular aggregates.

  2025cites this paper
• Botulism, Lambert-Eaton Myasthenic Syndrome, and Congenital Myasthenic Syndromes.

  2025cites this paper
• A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)

  2024cites this paper
• Phenotypic variability in congenital myasthenic syndrome with GFPT1 mutation

  2024cites this paper
• Limb-Girdle Type Congenital Myasthenic Syndrome Anticipated With Scoliosis: A Case Report

  2024cites this paper
• Functional overlap of inborn errors of immunity and metabolism genes defines T cell metabolic vulnerabilities

  2024cites this paper
• Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review

  2023cites this paper
• Pathogenic DPAGT1 variants in limb‐girdle congenital myasthenic syndrome (LG‐CMS) associated with tubular aggregates and ORAI1 hypoglycosylation

  2023cites this paper
• Agenesis of Pectoralis Major Muscle in Late-Onset GFPT1-Related Congenital Myasthenic Syndrome

  2023cites this paper
• Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction

  2023cites this paper
• The Hexosamine Biosynthesis Pathway: Regulation and Function

  2023cites this paper
• Functional Overlap of Inborn Errors of Immunity and Metabolism Genes Define T Cell Immunometabolic Vulnerabilities

  2023cites this paper
• The role of protein glycosylation in muscle diseases

  2022cites this paper
• Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature

  2022cites this paper
• Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation

  2021cites this paper
• Genetic defects are common in myopathies with tubular aggregates

  2021cites this paper
• Endplattenerkrankungen

  2020cites this paper
• Congenital myasthenic syndrome due to compound heterozygous mutations in the GFPT1 gene

  2020cites this paper
• Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT1

  2020cites this paper
• The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis

  2020cites this paper
• Congenital disorders of glycosylation: Still "hot" in 2020.

  2020cites this paper
• Trouble at the junction: When myopathy and myasthenia overlap

  2019cites this paper
• The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations

  2019cites this paper
• Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates.

  2019cites this paper
• The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations

  2019cites this paper
• Leukoencephalopathy due to variants in GFPT1-associated congenital myasthenic syndrome

  2019cites this paper
• Phenotype of a limb-girdle congenital myasthenic syndrome patient carrying a GFPT1 mutation.

  2019cites this paper
• Congenital myasthenic syndromes

  2019influential citation
• Myo-Glyco disease Biology: Genetic Myopathies Caused by Abnormal Glycan Synthesis and Degradation

  2019cites this paper
• Congenital disorders of glycosylation.

  2018cites this paper
• Myasthenic syndromes due to defects in COL13A1 and in the N‐linked glycosylation pathway

  2018cites this paper
• Clinical and research strategies for limb‐girdle congenital myasthenic syndromes

  2018cites this paper
• The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes

  2018cites this paper
• Rapid retrograde regulation of transmitter release at the NMJ

  2018cites this paper
• Mutations in GFPT 1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregates myopathy with synaptopathy

  2017cites this paper
• Clinical features of the myasthenic syndrome arising from mutations in GMPPB

  2017cites this paper
• Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy

  2017cites this paper
• Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations

  2017cites this paper
• Congenital myasthenic syndromes: recent advances.

  2016cites this paper
• Immediate and long-term transcriptional response of hind muscle tissue to transient variation of incubation temperature in broilers

  2016cites this paper
• Genetic defects in the hexosamine and sialic acid biosynthesis pathway.

  2016cites this paper
• Genetic Investigations of Sporadic Inclusion Body Myositis and Myopathies with Structural Abnormalities and Protein Aggregates in Muscle

  2016cites this paper
• Clinical features of the myasthenic syndrome arising from mutations in GMPPB

  2016cites this paper
• Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations

  2016cites this paper
• Identification of the molecular origins of disease in a cohort of patients with suspected congenital disorders of glycosylation (CDG)

  2016cites this paper
• Recent advances in congenital myasthenic syndromes

  2016cites this paper
• Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)

  2015cites this paper
• A 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome.

  2015cites this paper
• Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders

  2015cites this paper
• In search of a human self-regulation system.

  2015cites this paper
• Neurological aspects of human glycosylation disorders.

  2015cites this paper
• Protein Modifications in Pathogenic Dysregulation of Signaling

  2015cites this paper
• Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness

  2015cites this paper
• Molecular Signaling and Its Pathogenic Alterations in Neuromuscular Junction Formation and Maintenance

  2015cites this paper
• Congenital myasthenic syndromes and the neuromuscular junction.

  2014cites this paper
• Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

  2014cites this paper
• The clinical and genetic characteristics of congenital myasthenic syndromes

  2014cites this paper
• [Congenital myasthenic syndromes; French experience].

  2014cites this paper
• Inherited disorders of the neuromuscular junction: an update

  2014cites this paper
• Congenital myasthenic syndromes: an update

  2013cites this paper
• Congenital myasthenic syndromes.

  1997cites this paper
• This Work Is Licensed under a Creative Commons Attribution 4.0 International License Mutations in Gmppb Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies

  year unknowncites this paper